Management of High-Grade Dysplasia and Intramucosal Adenocarcinoma in Barrett's Esophagus

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 7, 2012, Pages 704-711

  Wani, Sachin ^a   Early, Dayna ^b   Edmundowicz, Steve ^b   Sharma, Prateek ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ARTICLE; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER STAGING; CRYOTHERAPY; DYSPLASIA; ENDOSCOPIC SURGERY; ESOPHAGUS PERFORATION; ESOPHAGUS STRICTURE; ESOPHAGUS SURGERY; HISTOPATHOLOGY; HUMAN; INTRAMUCOSAL ADENOCARCINOMA; POSTOPERATIVE HEMORRHAGE; RADIOFREQUENCY ABLATION;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ENDOSCOPY; HUMANS; MALE; MIDDLE AGED;

EID: 84862657194     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.03.030     Document Type: Article

References (56)

1. Sharma P. Clinical practice. Barrett's esophagus. N Engl J Med 2009, 361:2548-2556.
2. Spechler S.J., Sharma P., Souza R.F., et al. American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology 2011, 140:e18-e52.
3. Rastogi A., Puli S., El-Serag H.B., et al. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc 2008, 67:394-398.
4. Wani S., Falk G., Hall M., et al. Patients with nondysplastic Barrett's esophagus have low risks for developing dysplasia or esophageal adenocarcinoma. Clin Gastroenterol Hepatol 2011, 9:220-227.
5. Hvid-Jensen F., Pedersen L., Drewes A.M., et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011, 365:1375-1383.
6. Odze R.D. Diagnosis and grading of dysplasia in Barrett's oesophagus. J Clin Pathol 2006, 59:1029-1038.
7. Downs-Kelly E., Mendelin J.E., Bennett A.E., et al. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies. Am J Gastroenterol 2008, 103:2333-2340.
8. Wani S., Mathur S.C., Curvers W.L., et al. Greater interobserver agreement by endoscopic mucosal resection than biopsy samples in Barrett's dysplasia. Clin Gastroenterol Hepatol 2010, 8:783-788.
9. Wani S., Sayana H., Sharma P. Endoscopic eradication of Barrett's esophagus. Gastrointest Endosc 2010, 71:147-166.
10. Stein H.J., Feith M., Bruecher B.L., et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 2005, 242:566-573. Discussion:573-575.
11. Rice T.W., Zuccaro G., Adelstein D.J., et al. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg 1998, 65:787-792.
12. Badreddine R.J., Prasad G.A., Lewis J.T., et al. Depth of submucosal invasion does not predict lymph node metastasis and survival of patients with esophageal carcinoma. Clin Gastroenterol Hepatol 2010, 8:248-253.
13. Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 2005, 37:570-578. Endoscopic Classification Review Group.
14. Kara M.A., Peters F.P., Rosmolen W.D., et al. High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett's esophagus: a prospective randomized crossover study. Endoscopy 2005, 37:929-936.
15. Wani S., Sharma P. Endoscopic surface imaging of Barrett's esophagus: an optimistic view. Gastroenterology 2007, 133:11-13.
16. Kara M.A., Ennahachi M., Fockens P., et al. Detection and classification of the mucosal and vascular patterns (mucosal morphology) in Barrett's esophagus by using narrow band imaging. Gastrointest Endosc 2006, 64:155-166.
17. Mannath J., Subramanian V., Hawkey C.J., et al. Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta-analysis. Endoscopy 2010, 42:351-359.
18. Sharma P., Hawes R.H., Bansal A., et al. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett's oesophagus: a prospective, international, randomised controlled trial. Gut 2012 Feb 7, [Epub ahead of print].
19. Sharma P., Meining A.R., Coron E., et al. Real-time increased detection of neoplastic tissue in Barrett's esophagus with probe-based confocal laser endomicroscopy: final results of an international multicenter, prospective, randomized, controlled trial. Gastrointest Endosc 2011, 74:465-472.
20. Gaddam S., Mathur S.C., Singh M., et al. Novel probe-based confocal laser endomicroscopy criteria and interobserver agreement for the detection of dysplasia in Barrett's esophagus. Am J Gastroenterol 2011, 106:1961-1969.
21. Young P.E., Gentry A.B., Acosta R.D., et al. Endoscopic ultrasound does not accurately stage early adenocarcinoma or high-grade dysplasia of the esophagus. Clin Gastroenterol Hepatol 2010, 8:1037-1041.
22. Pouw R.E., Heldoorn N., Herrero L.A., et al. Do we still need EUS in the workup of patients with early esophageal neoplasia?. A retrospective analysis of 131 cases. Gastrointest Endosc 2011, 73:662-668.
23. May A., Günter E., Roth F., et al. Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut 2004, 53:634-640.
24. Pech O., Gunter E., Dusemund F., et al. Accuracy of endoscopic ultrasound in preoperative staging of esophageal cancer: results from a referral center for early esophageal cancer. Endoscopy 2010, 42:456-461.
25. Chemaly M., Scalone O., Durivage G., et al. Miniprobe EUS in the pretherapeutic assessment of early esophageal neoplasia. Endoscopy 2008, 40:2-6.
26. Wani S., Edmundowicz S., Abrams J.A., et al. Accuracy of endoscopic ultrasonography (EUS) in staging early neoplasia in Barrett's esophagus (BE): results from a large multicenter cohort study. Gastrointest Endosc 2011, 73(Suppl AB):166-167.
27. Larghi A., Lightdale C.J., Memeo L., et al. EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus. Gastrointest Endosc 2005, 62:16-23.
28. Peters F.P., Brakenhoff K.P., Curvers W.L., et al. Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett's esophagus. Gastrointest Endosc 2008, 67:604-609.
29. Moss A., Bourke M.J., Hourigan L.F., et al. Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit. Am J Gastroenterol 2010, 105:1276-1283.
30. Chennat J., Konda V.J., Ross A.S., et al. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma-an American single-center experience. Am J Gastroenterol 2009, 104:2684-2692.
31. Sayana H., Wani S., Keighley J., et al. Endoscopic mucosal resection (EMR) as a diagnostic tool in Barrett's esophagus (BE) patients with high-grade dysplasia (HGD) and early esophageal adenocarcinoma (EAC): a systematic review. Gastroenterology 2008, 132:W1878.
32. Wani S., Abrams J.A., Edmundowicz S., et al. Diagnostic endoscopic mucosal resection (EMR) leads to a change in histologic diagnosis in Barrett's esophagus (BE) patients with visible and flat neoplasia. Gastroenterology 2011, 140:S217-S218.
33. Prasad G.A., Wu T.T., Wigle D.A., et al. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterology 2009, 137:815-823.
34. Konda V.J., Ross A.S., Ferguson M.K., et al. Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated?. Clin Gastroenterol Hepatol 2008, 6:159-164.
35. Prasad G.A., Wang K.K., Buttar N.S., et al. Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology 2007, 132:1226-1233.
36. Pech O., Bollschweiler E., Manner H., et al. Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett's esophagus at two high-volume centers. Ann Surg 2011, 254:67-72.
37. Das A., Singh V., Fleischer D.E., et al. A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Am J Gastroenterol 2008, 103:1340-1345.
38. Inadomi J.M., Somsouk M., Madanick R.D., et al. A cost-utility analysis of ablative therapy for Barrett's esophagus. Gastroenterology 2009, 136. 2101-2114.e1-6.
39. Wani S., Puli S.R., Shaheen N.J., et al. Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am J Gastroenterol 2009, 104:502-513.
40. Pech O., Behrens A., May A., et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008, 57:1200-1206.
41. Pouw R.E., van Vilsteren F.G., Peters F.P., et al. Randomized trial on endoscopic resection-cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett's neoplasia. Gastrointest Endosc 2011, 74:35-43.
42. van Vilsteren F.G., Pouw R.E., Seewald S., et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut 2011, 60:765-773.
43. Pouw R.E., Seewald S., Gondrie J.J., et al. Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients. Gut 2010, 59:1169-1177.
44. Gerke H., Siddiqui J., Nasr I., et al. Efficacy and safety of EMR to completely remove Barrett's esophagus: experience in 41 patients. Gastrointest Endosc 2011, 74:761-771.
45. Okoro N.I., Tomizawa Y., Dunagan K.T., et al. Safety of prior endoscopic mucosal resection in patients receiving radiofrequency ablation of Barrett's esophagus. Clin Gastroenterol Hepatol 2012, 10:150-154.
46. Pouw R.E., Wirths K., Eisendrath P., et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett's esophagus with early neoplasia. Clin Gastroenterol Hepatol 2010, 8:23-29.
47. Shaheen N.J., Sharma P., Overholt B.F., et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009, 360:2277-2288.
48. Shaheen N.J., Overholt B.F., Sampliner R.E., et al. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology 2011, 141:460-468.
49. Vaccaro B.J., Gonzalez S., Poneros J.M., et al. Detection of intestinal metaplasia after successful eradication of Barrett's esophagus with radiofrequency ablation. Dig Dis Sci 2011, 56:1996-2000.
50. Dumot J.A., Vargo J.J., Falk G.W., et al. An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients. Gastrointest Endosc 2009, 70:635-644.
51. Shaheen N.J., Greenwald B.D., Peery A.F., et al. Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 2010, 71:680-685.
52. Halsey K.D., Chang J.W., Waldt A., et al. Recurrent disease following endoscopic ablation of Barrett's high-grade dysplasia with spray cryotherapy. Endoscopy 2011, 43:844-848.
53. Gupta N., Mathur S.C., Dumot J.A., et al. Adequacy of esophageal squamous mucosa specimens obtained during endoscopy: are standard biopsies sufficient for postablation surveillance in Barrett's esophagus?. Gastrointest Endosc 2012, 75:11-18.
54. Gray N.A., Odze R.D., Spechler S.J. Buried metaplasia after endoscopic ablation of Barrett's esophagus: a systematic review. Am J Gastroenterol 2011, 106:1899-1908.
55. Bronner M.P., Overholt B.F., Taylor S.L., et al. Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia. Gastroenterology 2009, 136:56-64.
56. Yachimski P., Falk G.W. Subsquamous intestinal metaplasia: implications for endoscopic management of Barrett's esophagus. Clin Gastroenterol Hepatol 2012, 10:220-224.